Prognosis in malignant mesothelioma related to MIB 1 proliferation index and histological subtype

被引:41
作者
Beer, TW [1 ]
Buchanan, R
Matthews, AW
Stradling, R
Pullinger, N
Pethybridge, RJ
机构
[1] Royal Hosp, Dept Histopathol, Haslar PO12 2AA, Hants, England
[2] Queen Alexandra Hosp, Dept Histopathol, Portsmouth, Hants, England
[3] Queen Alexandra Hosp, Dept Thorac Med, Portsmouth, Hants, England
[4] Inst Naval Med, Gosport PO12 2DL, Hants, England
关键词
malignant mesothelioma; proliferation; MIB; 1; prognosis;
D O I
10.1016/S0046-8177(98)90043-0
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The aims of this study were to evaluate the use of the proliferation marker MIB 1 and histological subtype as indicators of prognosis in malignant mesothelioma. Sections from 41 cases of malignant mesothelioma were histologically subtyped on hematoxylin and eosin sections and stained immunohistochemically for the proliferation marker MIB 1, A proliferation index was derived and the results compared with patient survival data. A statistically significant difference was found between the survival of patients having in low and high MIB 1 index (P < .001). Patients with tumors having a low MIB 1 index lived significantly longer than those with a high MIB 1 index. Patients with the spindle cell histological subtype of malignant mesothelioma had significantly shorter survival times than those with the epithelioid or mixed tumors (P < .01). The MIB 1 proliferation index and histological tumor subtype are useful markers of prognosis in malignant mesothelioma. Copyright (C) 1998 by W.B. Saunders Company.
引用
收藏
页码:246 / 251
页数:6
相关论文
共 36 条
[1]  
Achatzy R, 1989, Eur J Cardiothorac Surg, V3, P445, DOI 10.1016/1010-7940(89)90056-0
[2]   MALIGNANT PLEURAL MESOTHELIOMA - A DISEASE UNAFFECTED BY CURRENT THERAPEUTIC MANEUVERS [J].
ALBERTS, AS ;
FALKSON, G ;
GOEDHALS, L ;
VOROBIOF, DA ;
VANDERMERWE, CA .
JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (03) :527-535
[3]   INSITU END-LABELING DETECTS DNA STRAND BREAKS IN APOPTOSIS AND OTHER PHYSIOLOGICAL AND PATHOLOGICAL STATES [J].
ANSARI, B ;
COATES, PJ ;
GREENSTEIN, BD ;
HALL, PA .
JOURNAL OF PATHOLOGY, 1993, 170 (01) :1-8
[4]  
ANTMAN KH, 1993, CHEST, V103, P373
[5]  
BOUTIN C, 1993, CANCER, V72, P394, DOI 10.1002/1097-0142(19930715)72:2<394::AID-CNCR2820720214>3.0.CO
[6]  
2-5
[7]  
Boutin C, 1990, Rev Prat, V40, P1846
[8]   DIAGNOSTIC AND THERAPEUTIC STRATEGY IN MALIGNANT PLEURAL MESOTHELIOMA [J].
BRANSCHEID, D ;
KRYSA, S ;
BAUER, E ;
BULZEBRUCK, H ;
SCHIRREN, J .
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 1991, 5 (09) :466-473
[9]   MONOCLONAL-ANTIBODY KI-67 - ITS USE IN HISTOPATHOLOGY [J].
BROWN, DC ;
GATTER, KC .
HISTOPATHOLOGY, 1990, 17 (06) :489-503
[10]  
ENZINGER FM, 1995, SOFT TISSUE TUMORS, P787